Telehealth firm LifeMD said on Tuesday it would partner with Novo Nordisk to offer its diabetes drug Ozempic at $499 per ...

Alibaba, which has been gaining traction in AI demands, was up 4.7%, while Tilray, a pharmaceutical company, soared 60.9% ...

Morgan Stanley has downgraded Novo Nordisk, whose U.S. shares are already down a third this year. That downgrade forecasts ...

Monday's downgrading entity was white-shoe investment bank Morgan Stanley, whose analyst Thibault Boutherin felt compelled to ...

Novo Nordisk, the Danish maker of blockbuster drugs Ozempic and Wegovy, caught another downgrade Monday as analysts foresee ...

LifeMD (LFMD) stock is in focus as the firm expands its telehealth collaboration with Novo Nordisk to offer the pharma ...

Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic ...

Ozempic has been approved in India for type 2 diabetes. The blockbuster drug by Danish drugmaker Novo Nordisk has taken the ...

Novo Nordisk confirms the upcoming India launch of Ozempic, its once-weekly semaglutide injection for Type 2 diabetes and ...

LifeMD’s telehealth platform is seamlessly integrated with NovoCare ® Pharmacy to provide easy, reliable access to Novo Nordisk’s FDA-approved GLP-1 medications, Ozempic ® and Wegovy ®, at the most ...

Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor ...

The Danish drugmaker prepares to introduce its once-a-week injectable, Ozempic, as India faces rising cases of Type 2 ...